e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Update on monitoring airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Circulating nucleosomal DNA of blood as an indicator of the pathological process during chronical bronchitis
I. Vasilyeva, T. Ivtchik (Saint-Petersburg, Russian Federation)
Source:
Annual Congress 2011 - Update on monitoring airway diseases
Session:
Update on monitoring airway diseases
Session type:
Thematic Poster Session
Number:
4030
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Vasilyeva, T. Ivtchik (Saint-Petersburg, Russian Federation). Circulating nucleosomal DNA of blood as an indicator of the pathological process during chronical bronchitis. Eur Respir J 2011; 38: Suppl. 55, 4030
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis
Source: International Congress 2017 – Rare diseases
Year: 2017
Pulmonary senescence in chronic obstructive pulmonary disease is primarily mediated by persistent DNA double strand breaks
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Oxidative modification of proteins of blood plasma in patients with interstitial lung diseases
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Analysis of DNA repair synthesis in peripheral blood lymphocytes from patients with well-controlled and uncontrolled asthma
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
DNA damage as a molecular link in the pathogenesis of COPD in smokers
Source: Eur Respir J 2012; 39: 1368-1376
Year: 2012
Altered DNA methylation levels in the context of exposures and respiratory disease
Source: International Congress 2016 – Genetics, epigenetics and the exposome
Year: 2016
Blood mitochondrial DNA as a biomarker of clinical outcomes in idiopathic pulmonary fibrosis
Source: Eur Respir J, 56 (5) 2001769; 10.1183/13993003.01769-2020
Year: 2020
Effect of ultrafine particle matter on human peripheral blood mononuclear cells of chronic obstructive pulmonary disease patients: involvement of the inflammasome.
Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Year: 2017
Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Altered expression of long non-coding RNA in sputum and blood during pulmonary exacerbation in cystic fibrosis
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Biomarkers in peripheral blood from patients with chronic silicosis caused by artificial quartz agglomerates
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Relationship between arterial carboxyhemoglobin concentrations and other biological inflammatory indicators in patients with bacterial pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 355s
Year: 2002
Plasma mitochondrial DNA as a biomarker of disease progression in idiopathic pulmonary fibrosis
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Characteristic of cytokines levels of blood and sputum in COPD exacerbation
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Plasma inflammatory markers associated with bone resorption in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
The content of soluble forms of activated molecules of leukocytes in the blood serum of patients with chronic bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 36s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept